The Centers for Disease Control (CDC) is to purchase 5 million doses of an experimental COVID-19 vaccine by Medigen Vaccine Biologics Corp (高端疫苗), the Hsinchu-based firm said in a regulatory filing yesterday.
The procurement agreement also includes a subsequent purchase of up to 5 million more doses, Medigen said.
The company did not disclose further details, citing terms agreed with the CDC.
Photo: CNA
The delivery of the drug, pending approval, would have a positive effect on the firm’s finances and operations, it said.
Medigen, which is running a phase 2 clinical trial of the vaccine with 3,752 participants, told the Taipei Times earlier this month that it has started large-scale antigen production for the drug.
The company said it would in the middle of next month submit an interim report on the trial to health authorities and hopes that it will gain emergency use authorization for the drug as soon as possible, it has said.
Medigen on May 11 said that it had given a third dose of the vaccine to 45 participants of the trial to test the immunogenicity and safety of a potential booster shot.
Primary data on the trial would be generated early next quarter, it said, adding that these would also be used to study the drug’s efficacy to prevent infections with new COVID-19 variants and for future vaccine development.
Additional reporting by Kao Shih-ching
Cairo’s new monorail slices across the city skyline, running above the familiar chaos of blaring horns and aging buses’ exhaust fumes that mark rush hour below. The US$4.5 billion monorail, opened this month, is among Egypt’s most prominent new transport projects, part of a debt-funded infrastructure drive criticized for sapping state finances while bringing limited benefits to most of the country’s 109 million people. “It feels like you’re in a different country,” said Ramy Sayed, a restaurant manager, aboard a driverless Innovia 300 train. “No noise, no traffic, we’re not used to this.” The eastern line runs 56km from the bustling middle-class
Taiwanese firms have increased investment in the Philippines in recent years as Manila’s ties with Washington deepen and global supply chains continue to shift away from China, an expert at the Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) said yesterday. The Philippines had not been among Taiwanese investors’ top choices in Southeast Asia, CIER Taiwan ASEAN Studies Center director Kristy Hsu (徐遵慈) said at a seminar in Taipei. However, Taiwan’s investment in the country has grown significantly since the COVID-19 pandemic, reaching US $257 million last year, a high in recent years, she said. Although Taiwan’s total investment in the Philippines still lags
Intel Corp regards Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) as a longstanding partner, as the US chipmaker would continue outsourcing production of advanced chips to TSMC, Intel chief executive officer Lip-Bu Tan (陳立武) said yesterday. “I don’t look at people as competitors. I look at the collaboration... Nvidia is also, you know, a good friend,” Tan told a news conference following his keynote speech at the Computex trade show in Taipei. “It’s a very trusted partnership for us... We are a big, top customer for them, and we’re going to continue doing that,” he said, referring to TSMC, the world’s largest foundry
Artificial intelligence (AI) agents would supplant smartphones as the center of people’s digital lives, fundamentally reshaping personal devices and driving a major computing upgrade cycle, Qualcomm Inc CEO Cristiano Amon said yesterday. In his keynote speech for this year’s Computex trade show in Taipei, Amon said that the rise of "agentic AI" — AI systems capable of reasoning, planning and carrying out tasks autonomously — would transform how people interact with technology across phones, PCs, vehicles and wearable devices. Describing the technology as the next major evolution in computing, Amon said that "2026 is the year of agents.” For decades, smartphones have sat
RSS